AstraZeneca PLC
AZN | IL
Overview
Corporate Details
- ISIN(s):
- GB0009895292 (+925 more)
- LEI:
- PY6ZZQWO2IZFZC3IOL08
- Country:
- United Kingdom
- Address:
- 1 FRANCIS CRICK AVENUE, CB2 0AA CAMBRIDGE
- Website:
- https://www.astrazeneca.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
AstraZeneca PLC is a global, science-led biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of prescription medicines. The company's primary therapeutic areas include oncology, rare diseases, and biopharmaceuticals. With an extensive pipeline of projects, AstraZeneca aims to deliver innovative, life-changing medicines to patients worldwide. The company is pursuing a significant growth strategy, with a stated ambition to achieve $80 billion in total revenue by 2030, supported by substantial investments in its research and manufacturing capabilities.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for AstraZeneca PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-28 16:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 8.2 KB | |
| 2025-08-26 16:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.9 KB | |
| 2025-08-26 10:57 |
Major Shareholding Notification
|
Swedish | 10.9 KB | |
| 2025-08-21 16:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.7 KB | |
| 2025-08-21 11:37 |
Major Shareholding Notification
|
Swedish | 10.9 KB | |
| 2025-08-18 16:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 24.5 KB | |
| 2025-08-15 16:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.9 KB | |
| 2025-08-15 09:05 |
Major Shareholding Notification
|
Swedish | 10.9 KB | |
| 2025-08-12 16:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.7 KB | |
| 2025-08-12 09:36 |
Major Shareholding Notification
|
Swedish | 10.9 KB | |
| 2025-08-01 16:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 8.9 KB | |
| 2025-07-29 08:00 |
Earnings Release
H1 and Q2 2025 results
|
English | 911.5 KB | |
| 2025-07-29 08:00 |
Interim Report
|
English | 1.5 MB | |
| 2025-07-24 08:00 |
Regulatory News Service
Gefurulimab nanobody met Phase III endpoints
|
English | 20.4 KB | |
| 2025-07-22 08:00 |
Regulatory News Service
AstraZeneca plans to invest $50bn in the US
|
English | 14.2 KB |
Automate Your Workflow. Get a real-time feed of all AstraZeneca PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for AstraZeneca PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-13 | Philip Broadley | Other | Buy | 980 | 99,665.12 EUR |
| 2024-03-08 | Pascal Soriot | Other | Other | 105,238 | N/A |
| 2024-03-05 | Pascal Soriot | Other | Other | 17,702 | N/A |
| 2024-03-04 | Pascal Soriot | Other | Other | 109,872 | 11,076,196.32 EUR |
| 2024-03-04 | Aradhana Sarin | Other | Other | 59,125 | 5,960,391.25 EUR |
| 2023-12-12 | Anna Manz | Other | Buy | 487 | 49,623.16 EUR |
| 2023-11-22 | Michel Demare | Other | Buy | 1,000 | 101,700.00 EUR |
| 2023-11-21 | Michel Demare | Other | Buy | 1,000 | 101,052.24 EUR |
| 2023-04-28 | Michel Demare | Other | Buy | 2,000 | 234,020.00 EUR |
| 2023-03-23 | Pascal Soriot | Other | Other | 138,093 | N/A |
